Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis BIOCON

Max Ratio

Dividend Yield

0.39 %

5Y Dividend Growth

100.00 %

Consecutive Years

5Y Average Payout Ratio

19.69 %

Dividend History BIOCON

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.39 %
Consecutive Years 0
Forward Annual Dividend 1.50 INR
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y 14.87 %
Payout Ratio TTM 12.53 %
Dividend CAGR 10Y 1.84 %
Ex Dividend Date 07/04/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth BIOCON

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin BIOCON

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income BIOCON

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM BIOCON

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio BIOCON

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Biocon Limited BIOCON

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself BIOCON

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 97.58
Forward PE
Enterprise Value Revenue 3.98
Price Sales TTM 3.15
Enterprise Value EBITDA 17.64
Price Book MRQ 2.04

Biocon Limited Dividends: 0.13 % Yield, History, Payment Schedule

BIOCON
Current price
388.35 INR -21.6 INR (-5.28%)
Last closed 410.00 INR
ISIN INE376G01013
Sector Healthcare
Industry Biotechnology
Exchange National Stock Exchange of India
Capitalization 519 347 323 342 INR
Yield for 12 month +3.49 %
1Y
3Y
5Y
10Y
15Y
BIOCON
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+152 873 256 256 INR

Last Year

+147 804 760 112 INR

Current Quarter

+42 696 570 771 INR

Last Quarter

+39 485 187 717 INR

Current Year

+92 596 215 872 INR

Last Year

+91 889 030 504 INR

Current Quarter

+27 200 595 430 INR

Last Quarter

+25 410 594 919 INR
EBITDA 33 947 906 044 INR
Operating Margin TTM 8.44 %
Price to Earnings 97.58
Return On Assets TTM 1.78 %
PEG Ratio
Return On Equity TTM 2.55 %
Wall Street Target Price 37 061.65 INR
Revenue TTM 165 034 637 476 INR
Book Value 209.71 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 19.60 %
Dividend Yield 0.39 %
Gross Profit TTM 98 879 750 174 INR
Earnings per share 3.99 INR
Diluted Eps TTM 3.99 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -95.30 %
Profit Margin 2.95 %

Technical Indicators BIOCON

For 52 Weeks

291.10 INR 425.66 INR
50 Day MA 376.25 INR
Shares Short Prior Month
200 Day MA 356.34 INR
Short Ratio
Shares Short
Short Percent